CNTB
Connect Biopharma·NASDAQ
--
--(--)
--
--(--)
CNTB fundamentals
Connect Biopharma (CNTB) released its earnings on Nov 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.3098 (YoY --), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.3098
--
Report date
Nov 12, 2025
Earnings
EPS
Revenue
Revenue & Expenses
CNTB has released its 2025 Q3 earnings report, with revenue of 16.00K, reflecting a YoY change of -98.69%, and net profit of -17.20M, showing a YoY change of -33.58%. The Sankey diagram below clearly presents CNTB's revenue sources and cost distribution.
Key Indicators
Connect Biopharma (CNTB) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Connect Biopharma (CNTB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Connect Biopharma (CNTB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Connect Biopharma (CNTB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Connect Biopharma (CNTB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Connect Biopharma (CNTB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the market's earnings forecast for Connect Biopharma next quarter?What is the revenue and EPS growth rate for Connect Biopharma year over year?What is Connect Biopharma's latest dividend and current dividend yield?What does Connect Biopharma do and what are its main business segments?What were the key takeaways from Connect Biopharma’s earnings call?What is Connect Biopharma's gross profit margin?What guidance did Connect Biopharma's management provide for the next earnings period?Did Connect Biopharma beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
